References

Pancreatic cancer early detection • multiplex immunoassays • heritable genetic risk • cancer screening • 

[1] Partyka, O.; Pajewska, M.; Kwaśniewska, D.; Czerw, A.; Deptała, A.; Budzik, M.; Cipora, E.; Gąska, I.; Gazdowicz, L.; Mielnik, A.; et al. Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations. Cancers (Basel). 2023, 15, 1–11, doi:10.3390/cancers15143634.

[2]Klein, A.P. Pancreatic Cancer Epidemiology: Understanding the Role of Lifestyle and Inherited Risk Factors. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 493–502, doi:10.1038/s41575-021-00457-x.

[3] Pourshams, A.; Sepanlou, S.G.; Ikuta, K.S.; Bisignano, C.; Safiri, S.; Roshandel, G.; Sharif, M.; Khatibian, M.; Fitzmaurice, C.; Nixon, M.R.; et al. The Global, Regional, and National Burden of Pancreatic Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study Lancet Gastroenterol. Hepatol. 2019, 4, 934–947, doi:10.1016/S2468-1253(19)30347-4.

[4] Yu, J.; Yang, X.; He, W.; Ye, W. Burden of Pancreatic Cancer along with Attributable Risk Factors in Europe between 1990 and 2019, and Projections until 2039. Int. J. Cancer 2021, 149, 993–1001, doi:10.1002/ijc.33617.

[5] Hu, J.X.; Lin, Y.Y.; Zhao, C.F.; Chen, W.B.; Liu, Q.C.; Li, Q.W.; Gao, F. Pancreatic Cancer: A Review of Epidemiology, Trend, and Risk Factors. World J. Gastroenterol. 2021, 27, 4298–4321, doi:10.3748/wjg.v27.i27.4298.

[6] Partyka, Olga, et al. “Overview of pancreatic cancer epidemiology in europe and recommendations for screening in high-risk populations.” Cancers 15.14 (2023): 3634.

[7] Blackford, Amanda L., et al. “Pancreatic cancer surveillance and survival of high-risk individuals.” JAMA oncology 10.8 (2024): 1087-1096.

[8] Haan, David, et al. “Epigenomic blood-based early detection of pancreatic cancer employing cell-free DNA.” Clinical Gastroenterology and Hepatology 21.7 (2023): 1802-1809.

[9] Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV; CCGA Consortium. Sensitive and specific multi-cancer detection and localization using methylation signatures in cellfree DNA. Ann Oncol. 2020;31(6):745-759.